- Home
- SXTP vs SNOA Comparison
SXTP vs SNOA Comparison
Compare SXTP & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- SNOA
- Stock Information
- Founded
- SXTP 2010
- SNOA 1999
- Country
- SXTP United States
- SNOA United States
- Employees
- SXTP N/A
- SNOA N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- SNOA Health Care
- Exchange
- SXTP Nasdaq
- SNOA Nasdaq
- Market Cap
- SXTP 6.7M
- SNOA 6.9M
- IPO Year
- SXTP 2023
- SNOA 2007
- Fundamental
- Price
- SXTP $1.38
- SNOA $3.95
- Analyst Decision
- SXTP Buy
- SNOA
- Analyst Count
- SXTP 2
- SNOA 0
- Target Price
- SXTP $3.00
- SNOA N/A
- AVG Volume (30 Days)
- SXTP 287.4K
- SNOA 77.0K
- Earning Date
- SXTP 11-14-2025
- SNOA 11-07-2025
- Dividend Yield
- SXTP N/A
- SNOA N/A
- EPS Growth
- SXTP N/A
- SNOA N/A
- EPS
- SXTP N/A
- SNOA N/A
- Revenue
- SXTP $984,494.00
- SNOA $14,912,000.00
- Revenue This Year
- SXTP $81.41
- SNOA $23.00
- Revenue Next Year
- SXTP $83.17
- SNOA $24.59
- P/E Ratio
- SXTP N/A
- SNOA N/A
- Revenue Growth
- SXTP 128.70
- SNOA 17.43
- 52 Week Low
- SXTP $1.22
- SNOA $1.75
- 52 Week High
- SXTP $12.45
- SNOA $6.92
- Technical
- Relative Strength Index (RSI)
- SXTP 42.79
- SNOA 48.35
- Support Level
- SXTP $1.43
- SNOA $3.73
- Resistance Level
- SXTP $1.52
- SNOA $4.06
- Average True Range (ATR)
- SXTP 0.11
- SNOA 0.21
- MACD
- SXTP -0.02
- SNOA 0.01
- Stochastic Oscillator
- SXTP 6.12
- SNOA 55.88
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.